Associated tags: Sports medicine, Capital, Risk management, Hospital, Antibiotics, Pharmaceutical industry, DARPA, MD, Ankle, Patient, MBA, FDA, Sale, Pain, Failure, United, DOD, Foot, Embodiment
Locations: MICHIGAN, OHIO, NOTRE DAME
Patient,
ASC,
GIG,
Sterilization,
Partnership,
DePuy Synthes,
Magnesium,
Genesis,
MSK,
Navigation,
Cartilage,
MBA,
Technology management,
Software,
MDC,
FDA,
Marketing,
Digital health,
Ohio State University,
Growth,
Management GRAND RAPIDS, Mich., Jan. 22, 2024 /PRNewswire/ -- Genesis Innovation Group (GIG), a leader in medical device innovation, is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.
Key Points:
- GRAND RAPIDS, Mich., Jan. 22, 2024 /PRNewswire/ -- Genesis Innovation Group (GIG), a leader in medical device innovation, is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.
- Tim is passionate about developing people and delivering meaningful innovation for customers and patients.
- Genesis has enjoyed meaningful success in its short tenure as an innovation organization.
- Genesis seeks to continue this legacy of success and expand its footprint in the medical device innovation space through an enhanced leadership team and a refocused strategy centered around innovation and partnership.
Sports medicine,
MBA,
Foot,
DOD,
United,
Failure,
Pain,
Investment,
Multimedia,
Sale,
FDA,
Patient,
Capital,
Ankle,
MD,
Industry,
DARPA,
Pharmaceutical industry,
Antibiotics,
Hospital,
Risk management,
Embodiment They are redefining the future of rotator cuff repair by combining a biointegrative collagen implant with streamlined arthroscopic delivery and fully bioabsorbable anchor fixation.
Key Points:
- They are redefining the future of rotator cuff repair by combining a biointegrative collagen implant with streamlined arthroscopic delivery and fully bioabsorbable anchor fixation.
- In 2021, there were an estimated 670,000 rotator cuff repairs in the United States.1The goal of rotator cuff surgery is to repair the damaged tendon and restore mobility for patients.
- "We believe TAPESTRYRC sets a new standard in arthroscopic rotator cuff surgery," said Jeff Conroy, Chief Executive Officer of Embody .
- "Building on the clinical utility of TAPESTRY, now in a streamlined, all-in-one solution for arthroscopic rotator cuff surgery."
Investment,
Technology,
Software,
Diagnosis,
Biomarker,
Radiology,
Leadership,
Sale,
FDA,
CEO,
Acquisition,
Disease,
DNA,
Multimedia,
Patient,
Mark (given name),
Lists of diseases,
Parkinson's disease,
Capital,
View,
MRI,
Brain,
Research,
Anatomy,
Medical imaging STAGE is a powerful, rapid, multi-contrast imaging method that allows scanning the entire brain in roughly five minutes, unlocking the full potential of MRI.
Key Points:
- STAGE is a powerful, rapid, multi-contrast imaging method that allows scanning the entire brain in roughly five minutes, unlocking the full potential of MRI.
- STAGE also collects other conventional images, with enhanced contrast, automatically delivering clinical image data back into the radiologists' workstations.
- The FDA Clearance allows us to utilize STAGE to help patients in real clinical environments."
- Matt Ahearn, Managing Director, cultivate(MD) Capital Funds said, "FDA clearance of STAGE sets the foundation for SpinTech's initial commercialization and scale.
Retrieved on:
Tuesday, November 17, 2020
OtoSetTM, operating on a 35 second cleaning cycle, uses irrigation and microsuction to break down and remove impacted earwax.
Key Points:
- OtoSetTM, operating on a 35 second cleaning cycle, uses irrigation and microsuction to break down and remove impacted earwax.
- OtoSet's design makes the device easy to use and clean, and features disposable single patient use ear tips and disposable waste containers.
- "The SafKan Health team is passionate about the innovation they are delivering with the introduction of OtoSetTM.
- Founded in 2016, SafKan Health has developed the first automated and FDA Cleared ear cleaning device, OtoSetTM SafKan Health's clinical advisors include industry-leading primary care physicians and otolaryngologists from the University of Washington Medicine, Kaiser Permanente, Cedars-Sinai, and UCR Health.
Retrieved on:
Thursday, October 29, 2020
Embody is a privately-held medical device company developing novel collagen-based technologies for sports medicine and soft tissue repair.
Key Points:
- Embody is a privately-held medical device company developing novel collagen-based technologies for sports medicine and soft tissue repair.
- TAPESTRY is a bioengineered collagen-based implant with a proprietary micro-architecture specifically designed for tendon and ligament repair.
- TAPESTRY represents a significant advancement in collagen science and provides surgeons with a compelling solution with broad clinical utility for tendon repair procedures," said Jeff Conroy, CEO of Embody.
- Embody's TAPESTRY implant represents a breakthrough in implant design that combines the benefits of collagen with the structural integrity required for demanding tendon and ligament applications from foot & ankle to complex shoulder repair procedures."
HOLLAND, Mich., April 18, 2019 /PRNewswire/ --Genesis Innovation Group's Shoulder Innovations (SI) is focused on human centered design.
Key Points:
- HOLLAND, Mich., April 18, 2019 /PRNewswire/ --Genesis Innovation Group's Shoulder Innovations (SI) is focused on human centered design.
- Shoulder Innovations' customer base has embraced the InSet Glenoid technology wholeheartedly in the past 24 months leading to 1,000 glenoid surgical cases.
- The company now also offers the FDA cleared InSet Short Stem Humeral component as part of the InSet Total Shoulder System.
- Rob Ball, Executive Chairman of Shoulder Innovations said, "Shoulder Innovations' passion has been to deeply engage shoulder specialists in the development of innovative shoulder products that will pave the way for the future.
HOLLAND, Mich., Dec.3, 2018 /PRNewswire/ --Genesis Innovation Group's cultivate(MD) Capital Fund II, LP , a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into SpinTech.
Key Points:
- HOLLAND, Mich., Dec.3, 2018 /PRNewswire/ --Genesis Innovation Group's cultivate(MD) Capital Fund II, LP , a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into SpinTech.
- SpinTech has developed a suite of software that offers innovative advancements for brain scan MRIs.
- Ward Detwiler, CEO of the Detroit, MI-based SpinTech said, "We are pleased to have received this investment from Genesis Innovation Group's cultivate(MD) fund and the support of their team, not only from the investment side but also for their operational experience in the start-up environment ."
- The investment funds will be used to support commercialization of our first FDA cleared product while expanding pilot testing of our next generation products.
